StockData
Ceribell, Inc. logo

Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.97−0.45 (-1.70%)

Close on Nov 17, 2026Market cap $996.68MP/E –Yield –

Ceribell operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Ceribell's operating income for the twelve months ending Jun 30, 2026 was -$69.97M. For fiscal 2025 it was -$58.40M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$58.40M–
FY2024Dec 31, 2024-$39.71M–
FY2023Dec 31, 2023-$30.04M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$19.98M–
Q1 FY2026Mar 31, 2026-$20.75M–
Q4 FY2025Dec 31, 2025-$14.60M–
Q3 FY2025Sep 30, 2025-$14.65M–
Q2 FY2025Jun 30, 2025-$14.95M–
Q1 FY2025Mar 31, 2025-$14.21M–
Q4 FY2024Dec 31, 2024-$12.88M–
Q3 FY2024Sep 30, 2024-$9.94M–
Q2 FY2024Jun 30, 2024-$8.44M–
Q1 FY2024Mar 31, 2024-$8.45M–
Q4 FY2023Dec 31, 2023-$8.38M–
Q3 FY2023Sep 30, 2023-$7.16M–

More Ceribell figures

See a number that looks wrong?